Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren’s syndrome
Roberto Giacomelli,
Giuliana Guggino,
Francesco Ciccia,
Onorina Berardicurti,
Riccardo Alessandro,
Stefania Raimondo,
Francesco Dieli,
Giuseppina Campisi,
Chiara Rizzo,
Leila Mohammadnezhad,
Marianna Lo Pizzo,
Vincenzo Luca Lentini,
Diana Di Liberto,
Lidia La Barbera,
Mojtaba Shekarkar Azgomi,
Ornella Urzì
Affiliations
Roberto Giacomelli
Research and Clinical Unit of Immunorheumatology, Department of Medicine and Surgery, Università Campus Bio-Medico, Rome, Italy
Giuliana Guggino
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section - “P. Giaccone”, University of Palermo, Palermo, Sicilia, Italy
Francesco Ciccia
Department of Precision Medicine, University of Campania Luigi Vanvitelli School of Medicine and Surgery, Napoli, Campania, Italy
Onorina Berardicurti
Unit of Allergology, Immunology, Rheumatology, Campus Bio-Medico University Hospital, Roma, Lazio, Italy
Riccardo Alessandro
Department of Biomedicine, Neuroscience and Advanced Diagnostics, Section of Biology and Genetics, University of Palermo, Palermo, Sicilia, Italy
Stefania Raimondo
Department of Biomedicine, Neuroscience and Advanced Diagnostics, Section of Biology and Genetics, University of Palermo, Palermo, Sicilia, Italy
Francesco Dieli
Department of Biomedicine, Neuroscience and Advanced Diagnostic, Immunology Section, University of Palermo, Palermo, Sicilia, Italy
Giuseppina Campisi
Department of Surgical, Oncological and Oral Sciences - “P. Giaccone” University Hospital, University of Palermo, Palermo, Sicilia, Italy
Chiara Rizzo
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section - “P. Giaccone”, University of Palermo, Palermo, Sicilia, Italy
Leila Mohammadnezhad
Department of Biomedicine, Neuroscience and Advanced Diagnostic, Immunology Section, University of Palermo, Palermo, Sicilia, Italy
Marianna Lo Pizzo
Department of Biomedicine, Neuroscience and Advanced Diagnostic, Immunology Section, University of Palermo, Palermo, Sicilia, Italy
Vincenzo Luca Lentini
Pathology Unit, Villa Sofia Cervello United Hospitals, Palermo, Sicilia, Italy
Diana Di Liberto
Department of Biomedicine, Neuroscience and Advanced Diagnostic, Immunology Section, University of Palermo, Palermo, Sicilia, Italy
Lidia La Barbera
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section - “P. Giaccone”, University of Palermo, Palermo, Sicilia, Italy
Mojtaba Shekarkar Azgomi
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Rheumatology section - “P. Giaccone”, University of Palermo, Palermo, Sicilia, Italy
Ornella Urzì
Department of Biomedicine, Neuroscience and Advanced Diagnostics, Section of Biology and Genetics, University of Palermo, Palermo, Sicilia, Italy
Objectives Aim of this study was to investigate the expression of interleukin (IL)-40, a new cytokine associated with B cells homoeostasis and immune response, in primary Sjögren syndrome (pSS) and in pSS-associated lymphomas.Methods 29 patients with pSS and 24 controls were enrolled. Minor salivary gland (MSG) biopsies from patients, controls and parotid gland biopsies from pSS-associated lymphoma were obtained. Quantitative gene expression analysis by TaqMan real-time PCR and immunohistochemistry for IL-40 were performed on MSG. MSG cellular sources of IL-40 were determined by flow-cytometry and immunofluorescence. Serum concentration of IL-40 was assessed by ELISA and cellular sources of IL-40 were determined by flow-cytometry. An in vitro assay with recombinant IL-40 (rIL-40) was performed to detect the effect on cytokine production from peripheral blood mononuclear cells (PBMCs).Results IL-40 was significantly increased in the lymphocytic infiltrated MSG of patients with pSS and correlated with focus score and with IL-4 and transforming growth factor-β expression. In addition, IL-40 was increased in the serum of pSS and its levels correlated with the EULAR Sjögren’s Syndrome Disease Activity Index score. B cells from patients were shown to be the major source of IL-40 at both tissue and peripheral level. PBMCs from patients, exposed to rIL-40 in vitro, released proinflammatory cytokines, specifically interferon-γ from B cells and T-CD8+ and tumour necrosis factor-α and IL-17 from both T-CD4+ and T-CD8+. IL-40 expression in parotid glands of pSS-associated lymphomas was also increased. Moreover, IL-40-driven NETosis was evidenced in neutrophils obtained from pSS.Conclusion Our results suggest that IL-40 may play a role in pSS pathogenesis and pSS-associated lymphomas.